Therefore, it can be expected that C21 will allow the effects of the AT2 receptor in cardiac hypertrophy to be studied by means of direct, selective AT2 receptor stimulation, which will hopefully help to overcome current controversies [36]. This evidence concerns the gene AGTR2 and cardiac hypertrophy.